Sound Shore Management Inc /CT/
Managed by Harry Burn. $3.14B disclosed long-equity portfolio across 37 positions.
| # | Stock | Value | % of Portfolio |
|---|---|---|---|
| 1 | Regeneron Pharmaceuticals, Inc. | $135.8M | 4.32% |
| 2 | Teva Pharmaceutical Industries | $134.5M | 4.28% |
| 3 | Alphabet Inc. Cl A | $109.5M | 3.48% |
| 4 | Public Service Enterprise | $109.4M | 3.48% |
| 5 | The Walt Disney Company | $109.1M | 3.47% |
| 6 | Berkshire Hathaway, Inc. C | $105.7M | 3.36% |
| 7 | Southwest Airlines Co. | $104.2M | 3.32% |
| 8 | QUALCOMM Incorporated | $100.7M | 3.21% |
| 9 | Salesforce, Inc. | $100.3M | 3.19% |
| 10 | The AES Corporation | $98.9M | 3.15% |
| 11 | Kinder Morgan, Inc. | $93.2M | 2.97% |
| 12 | Citigroup Inc. | $92.1M | 2.93% |
| 13 | Fidelity National Information Services | $92.0M | 2.93% |
| 14 | Incyte Corporation | $91.8M | 2.92% |
| 15 | Capital One Financial Corp | $88.6M | 2.82% |
| 16 | CSX Corporation | $87.1M | 2.77% |
| 17 | Bank of America Corporation | $86.8M | 2.76% |
| 18 | General Motors Company | $86.7M | 2.76% |
| 19 | Marvell Technology, Inc. | $86.2M | 2.74% |
| 20 | Coterra Energy, Inc. | $86.1M | 2.74% |
| 21 | Wells Fargo & Company | $85.7M | 2.73% |
| 22 | GE HealthCare Technologies | $83.5M | 2.66% |
| 23 | EQT Corporation | $81.3M | 2.59% |
| 24 | Kyndryl Holdings, Inc. | $79.0M | 2.51% |
| 25 | Check Point Software Technologies | $78.8M | 2.51% |
For full quarterly history, transactions, and the investor profile, see Harry Burn's page →
More related to Harry Burn 0000820124
Compare with other superinvestors
Other superinvestors
By investing strategy
Sound Shore Management Inc /CT/ — overview
Harry Burn runs Sound Shore Management Inc /CT/, a multi-strategy investment firm tracked here via SEC 13F filings. As of the Q4 2025 13F filing, the disclosed long-equity portfolio is valued at $3.1B across 37 positions. The largest holdings are Regeneron Pharmaceuticals, Inc., Teva Pharmaceutical Industries, and Alphabet Inc. Cl A (Regeneron Pharmaceuticals, Inc. alone is 4.3% of the book).
Key takeaways
- Disclosed Q4 2025 portfolio: $3.1B.
- Top holdings: Regeneron Pharmaceuticals, Inc., Teva Pharmaceutical Industries, and Alphabet Inc. Cl A.